Par Drugs & Chemical Stock Screener | Share Price & Fundamental Analysis
PAR
Pharmaceuticals
Screen Par Drugs & Chemical share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹93.74
▼
-3.49 (-3.59%)
Market Cap
₹132.24 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.21
EPS (TTM)
₹10.86
Dividend Yield
-
Debt to Equity
-
52W High
₹110.81
52W Low
₹86.30
Operating Margin
13.00%
Profit Margin
9.80%
Revenue (TTM)
₹102.00
EBITDA
₹17.00
Net Income
₹10.00
Total Assets
₹119.00
Total Equity
₹99.00
Par Drugs & Chemical Share Price History - Stock Screener Chart
Screen PAR historical share price movements with interactive charts. Analyze price trends and patterns.
Par Drugs & Chemical Company Profile - Fundamental Screener
Screen Par Drugs & Chemical company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE04LG01015
Par Drugs & Chemical Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen PAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 119 | 102 | 89 | 79 | 76 | 60 | 51 | 54 | 56 |
| Current Assets | 55 | 60 | 49 | 44 | 41 | 24 | 14 | 14 | 14 |
| Fixed Assets | 39 | 41 | 38 | 34 | 30 | 34 | 36 | 39 | 42 |
| Liabilities | |||||||||
| Total Liabilities | 119 | 102 | 89 | 79 | 76 | 60 | 51 | 54 | 56 |
| Current Liabilities | 4 | 4 | 4 | 4 | 8 | 9 | 10 | 16 | 17 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 99 | 86 | 71 | 60 | 52 | 41 | 29 | 21 | 20 |
| Share Capital | 12 | 12 | 12 | 12 | 6 | 6 | 5 | 9 | 9 |
| Reserves & Surplus | 87 | 73 | 59 | 48 | 46 | 35 | 25 | 13 | 11 |
Screen PAR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 102 | 103 | 96 | 96 | 75 | 61 | 56 | 46 | 42 | 49 |
| Expenses | 85 | 82 | 73 | 78 | 59 | 45 | 46 | 38 | 34 | 40 |
| EBITDA | 17 | 22 | 23 | 18 | 16 | 16 | 10 | 8 | 8 | 9 |
| Operating Profit % | 13.00% | 19.00% | 24.00% | 19.00% | 22.00% | 26.00% | 17.00% | 18.00% | 19.00% | 18.00% |
| Depreciation | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| Profit Before Tax | 13 | 18 | 20 | 15 | 13 | 15 | 6 | 3 | 3 | 3 |
| Tax | 3 | 5 | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 2 |
| Net Profit | 10 | 13 | 15 | 11 | 9 | 12 | 5 | 3 | 2 | 2 |
| EPS | 7.90 | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 5.60 | 5.64 | 6.50 |
Par Drugs & Chemical Cash Flow Screener - Liquidity Fundamentals
Screen PAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 16 | 20 | 13 | 8 | 12 | 8 | 2 | 4 | 9 | 7 |
| Investing Activities | -25 | -6 | -7 | -3 | 0 | -2 | 0 | -1 | -2 | 0 |
| Financing Activities | 0 | 0 | 0 | -10 | 2 | 1 | -2 | -4 | -8 | -6 |
| Net Cash Flow | -9 | 14 | 6 | -5 | 14 | 7 | 0 | 0 | -1 | 1 |
Screen PAR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.37% | 73.37% | 73.37% | 73.37% | 73.37% | 74.21% | 74.21% | 74.21% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.27% | 20.26% | 20.30% | 22.86% | 19.42% | 20.09% | 20.46% | 21.23% |
| Other Holding | 6.37% | 6.37% | 6.33% | 3.77% | 7.21% | 5.71% | 5.34% | 4.50% |
| Shareholder Count | 14,280 | 14,887 | 15,472 | 17,199 | 8,757 | 8,022 | 7,403 | 7,020 |
Par Drugs & Chemical Dividend Screener - Share Yield Analysis
Screen PAR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹2.50 | 4.04% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Par Drugs & Chemical Index Membership - Market Screener Classification
Screen PAR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Par Drugs & Chemical Market Events Screener - Corporate Actions
Screen PAR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 2.55% | ||
| 2025-12-31 | 2025-12-31 | Extraordinary General Meeting | NA | -14.97% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.43% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -8.56% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | -0.65% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -14.79% |
| 2025-02-12 | 2025-02-12 | Extraordinary General Meeting | NA | -9.70% |
| 2025-02-05 | 2025-02-05 | Extraordinary General Meeting | NA | -2.49% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | 5.27% |
| 2021-11-22 | 2021-11-23 | Dividend | ₹ 1.25 /share | -32.38% |
| 2021-04-27 | 2021-04-28 | Bonus | 1:1 | 3.44% |
Par Drugs & Chemical Competitors Screener - Peer Comparison
Screen PAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Par Drugs & Chemical Company Announcements - News Screener
Screen PAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-13 | Action(s) taken or orders passed | View |
| 2025-11-14 | Copy of Newspaper Publication | View |
| 2025-11-13 | Outcome of Board Meeting | View |
| 2025-11-13 | Outcome of Board Meeting | View |
| 2025-11-13 | Updates | View |
| 2025-11-13 | Outcome of Board Meeting | View |
| 2025-11-03 | Copy of Newspaper Publication | View |
| 2025-10-27 | Action(s) taken or orders passed | View |
| 2025-10-08 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | View |
| 2025-10-03 | Updates | View |
| 2025-09-29 | Appointment | View |
| 2025-09-29 | Trading Window | View |
| 2025-09-28 | Appointment | View |
| 2025-09-28 | Appointment | View |
| 2025-09-28 | Appointment | View |
| 2025-09-28 | Appointment | View |
| 2025-09-28 | Shareholders meeting | View |
| 2025-09-28 | Appointment | View |
| 2025-09-27 | Shareholders meeting | View |
| 2025-09-27 | General Updates | View |